← Leaderboards
Joan C Lo
University Of California San Francisco
$7,593,122
Attributed
$7,593,122
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $679.2K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,593,122 · 5
By mechanism
R01$7,292,486 · 4
M01$300,636 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Rosemary J Akhurst$18,718,924
- Jennifer S Haas$18,455,741
- Tooru Nemoto$7,267,731
- Kathleen D Liu$7,207,018
- Karla M Kerlikowske$18,081,417
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanCaliforniaPopulation BasedBisphosphonateSubgroupFractureSpine Bone StructureHip FracturesRaceReportingHip Region StructurePharmaceutical PreparationsOsteoporosisOsteoporosis With Pathological FractureAreaFemoral FracturesCountryEventMemberCaucasiansEpidemiologyIncidenceBaseChronic
Grant awards (18)
Skeletal Health Outcomes among US Asian Women$544,182
R01 · FY2025 · AG · contact PI
Skeletal Health Outcomes among US Asian Women$558,569
R01 · FY2024 · AG · contact PI
Skeletal Health Outcomes among US Asian Women$555,289
R01 · FY2023 · AG · contact PI
Skeletal Health Outcomes among US Asian Women$568,409
R01 · FY2022 · AG · contact PI
Skeletal Health Outcomes among US Asian Women$555,289
R01 · FY2021 · AG · contact PI
Femur Fracture Outcomes Associated with Bisphosphonate Use$679,239
R01 · FY2018 · AG · contact PI
Femur Fracture Outcomes Associated with Bisphosphonate Use$506,332
R01 · FY2017 · AG · contact PI
Femur Fracture Outcomes Associated with Bisphosphonate Use$153,341
R01 · FY2017 · AG · contact PI
Femur Fracture Outcomes Associated with Bisphosphonate Use$491,589
R01 · FY2016 · AG · contact PI
Femur Fracture Outcomes Associated with Bisphosphonate Use$491,589
R01 · FY2015 · AG · contact PI
ESRD Endocrinopathy and Daily Dialysis$226,566
R01 · FY2012 · DK · contact PI
ESRD Endocrinopathy and Daily Dialysis$226,411
R01 · FY2011 · DK · contact PI
ESRD Endocrinopathy and Daily Dialysis$205,801
R01 · FY2010 · DK · contact PI
Pregnancy Outcomes in Polycystic Ovary Syndrome$531,411
R01 · FY2009 · HD · contact PI
Pregnancy Outcomes in Polycystic Ovary Syndrome$496,140
R01 · FY2008 · HD · contact PI
Pregnancy Outcomes in Polycystic Ovary Syndrome$502,329
R01 · FY2007 · HD · contact PI
BONE MINERAL DENSITY AND BONE METABOLISM IN HIV$109,159
M01 · FY2005 · RR
Bone mineral density and bone metabolism in HIV$191,477
M01 · FY2004 · RR